An assessment of the safety and tolerability of immune globulin intravenous (human) Sandoglobulin prepared in sterile water or 5% dextrose at various concentrations.
Miller
K B
KB
Division of Hematology, Tufts University, New England Medical Center, Boston, MA 02111.
Schenkein
D P
DP
Fogaren
T
T
D000293:Adolescent; D000328:Adult; D004417:Dyspnea / Q000209:etiology; D005612:Freeze Drying; D005947:Glucose; D006801:Humans; D006973:Hypertension / Q000209:etiology; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D012996:Solutions; D013610:Tachycardia / Q000209:etiology; D014867:Water
D016756:Immunoglobulins, Intravenous; D012996:Solutions; D014867:Water; D005947:Glucose